Could cause temporary or reversible harm; serious harm is unlikely.
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
| Brand name | ATROPINE SULFATE |
| Generic name | ATROPINE SULFATE |
| Active ingredient(s) | ATROPINE SULFATE |
| Distributed by / for | American Regent, Inc. |
| NDC | 0517-1001-01 |
| Full product label | Atropine Sulfate injection, USP, 1 mg/mL, For intravenous Use, Sterile, packaged in a) 1 mL Single-Dose Vial (NDC 0517-1001-01), and b) 25x1 mL Single-Dose Vial (NDC 0517-1001-25), Rx only, AMERICAN REGENT INC., SHIRLEY, NY 11967. |
| Recalling firm | American Regent, Inc. |
| Distribution | Nationwide within the U.S |
| Quantity | 89,775 vials |
| Recall initiated | 2026-07-24 |
| Report date | 2026-08-26 |
| Recall completed | — |
| Recall number | D-0795-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Shirley NY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗